DEMANT Demant A/S

William Demant Holding A/S: Investor news - agenda and presentations for Capital Markets Day 2018

William Demant Holding A/S: Investor news - agenda and presentations for Capital Markets Day 2018



Investor news                                                                                          12 June 2018

Agenda and presentations for Capital Markets Day 2018

William Demant Holding A/S will today host its Capital Markets Day 2018 in London with the following agenda:

09:30Registration
10:00Welcome
10:05Broad hearing healthcare strategy driving long-term growth
10:35Innovation as a competitive advantage
12:45Operational excellence in Retail
14:30Opening up the world of sound with hearing implants
16:15Commitment to long-term shareholder value
16:45Closing remarks and Q&A
17:30End of formal programme

The purpose of the Capital Markets Day is to provide an update on the Company’s positioning, strategic direction and market dynamics. There are no changes to the current financial guidance.

Presentations for the event are available on the Company’s website . The Capital Markets Day will not be webcast live, but a video of the presentations will be made available on the Company’s website within a week from today.

*******

Further information:

Søren B. Andersson, VP IR

Phone

Other contacts:

Mathias Holten Møller, IR Officer

Trine Kromann‐Mikkelsen, VP Corporate Communication and Relations

 

Attachment

EN
12/06/2018

Underlying

DEMANTDemant A/S

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Demant A/S

Rune Majlund Dahl
  • Rune Majlund Dahl
Free Trial
DEMANT DEMANT A/S

Demant (Buy, TP: DKK400.00) - Improved long-term outlook

At its CMD, Demant updated its long-term outlook. It now targets 8–10% LCY growth (7–10%) including 6–8%-points organic growth and c2%-points M&A growth, and still sees incremental EBIT margin expansion. It expects the hearing-aid market to grow 4–6% p.a. in value (2–5%), as ASP is now guided fairly flat. We are positive on the Sirius-based Oticon Intent launch. We reiterate our BUY, and have raised our target price to DKK400 (375).

03/12/24 March 12, 2024 1 EN
Bruno Cavalier ... (+2)
  • Bruno Cavalier
  • Konrad Zomer
REL RELX PLC
AC ACCOR SA
HEIA HEINEKEN NV
SREN SWISS RE AG
SU SCHNEIDER ELECTRIC SE
MC LVMH MOET HENNESSY LOUIS VUITTON SE
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
DEMANT DEMANT A/S
EL ESSILORLUXOTTICA SA
TEP TELEPERFORMANCE SE
BRBY BURBERRY GROUP PLC
KER KERING SA
ENI ENI S.P.A.
01913 PRADA S.P.A.
MONC MONCLER SPA
CFR COMPAGNIE FINANCIERE RICHEMONT SA
EVD CTS EVENTIM AG & CO. KGAA
SIK SIKA AG
ADYEN ADYEN NV
02/19/24 February 19, 2024 1 EN
Bruno Cavalier ... (+2)
  • Bruno Cavalier
  • Konrad Zomer
REL RELX PLC
AC ACCOR SA
HEIA HEINEKEN NV
SREN SWISS RE AG
SU SCHNEIDER ELECTRIC SE
MC LVMH MOET HENNESSY LOUIS VUITTON SE
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
DEMANT DEMANT A/S
EL ESSILORLUXOTTICA SA
TEP TELEPERFORMANCE SE
BRBY BURBERRY GROUP PLC
KER KERING SA
ENI ENI S.P.A.
01913 PRADA S.P.A.
MONC MONCLER SPA
CFR COMPAGNIE FINANCIERE RICHEMONT SA
EVD CTS EVENTIM AG & CO. KGAA
SIK SIKA AG
ADYEN ADYEN NV
02/19/24 February 19, 2024 1 FR
Oliver Metzger
  • Oliver Metzger
DEMANT DEMANT A/S

Demant A/S : Strong performance to continue

>Strong performance to continue - Demant’s Q4 results showed, with an organic growth of 10%, a continuation of the strong performance of previous quarters. On the back of the announced launch of the new hearing aid platform Oticon Intega, we expect that the market share gains in the hearing aid segment will continue also in 2024. Our organic growth forecast for 2024 stands at 7.4% (guidance 4-8%) for the company driven by an expected 8.0% for the hearing aid wholesale...

02/19/24 February 19, 2024 1 EN
Martin Marandon-Carlhian ... (+3)
  • Martin Marandon-Carlhian
  • Stephane Houri
  • Thomas Zlowodzki
INFINEON INFINEON TECHNO...
DEMANT DEMANT A/S ... (+8)

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 02/06/2024

Today we are adding CRH to the ODDO BHF European Large Caps Convictions List. It is exposed to the US economy, which we believe will continue to outperform the European economy, as borne out by the very robust job creation figures released last Friday. CRH generates 75% of its EBITDA in the 10 fastest-growing US states, and also has positive technical catalysts such as its future inclusion in the S&P TMI and Russell 1000 indices. - ...

INFINEON INFINEON TECHNOLOGIES AG
DEMANT DEMANT A/S
FRE FRESENIUS SE & CO. KGAA
CRG CRH PLC
BP. BP P.L.C.
DHER DELIVERY HERO SE
VOD VODAFONE GROUP PLC
NOVO B NOVO NORDISK A/S
02/06/24 February 6, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch